MYCOSTATIN susp 100000 U/ml fl 24 ml

7680330430154 CH-33043 A07AA02 08.06.0.
MYCOSTATIN susp 100000 U/ml fl 24 ml
MYCOSTATIN susp 100000 U/ml fl 24 ml
MYCOSTATIN susp 100000 U/ml fl 24 ml
1 / 3
google

Details

Product number
3304301
CPT
-
Packaging group
24
Unit
ml
Composition
nystatinum 100000 U.I., saccharum 500 mg, glycerolum, saccharinum natricum, carmellosum natricum, dinatrii phosphas dihydricus, E 218 1 mg, propylis parahydroxybenzoas 0.2 mg, ethanolum 8.16 mg, aromatica (cerise) cum alcohol benzylicus, menthae piperitae aetheroleum, cinnamaldehydum, natrii hydroxidum, acidum hydrochloridum, aqua purificata ad suspensionem pro 1 ml corresp. natrium max. 0.78 mg.

Articles (1)

Mycostatin, suspension buvable/buccale
suspension
24
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
01/09/2025
Patient information leaflet
Français
01/09/2025
Patient information leaflet
Italien
01/09/2025
Professional SmPC
Allemand
01/09/2025
Professional SmPC
Français
01/09/2025
Professional SmPC
Italien
01/09/2025

Detailed composition

Substance Quantity Type Category
(N/A)
100000.0 UI Substance Wirkstoff (Principe actif)
(N/A)
500.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance AIMDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.0 MG Substance HBESI
(N/A)
0.2 MG Substance HBESI
(N/A)
8.16 MG Substance HBESI
(N/A)
- Substance AROMA
(N/A)
- Substance HBESI
(N/A)
- Substance AROMA
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI

Reimbursement information

Public price
CHF 12.35
Specialties list
Yes
Generic
No
SL addition date: 15/03/1956

Authorization holder

Labatec Pharma SA

1217 Meyrin

Authorization information

Swissmedic authorization number
33043
Drug name
Mycostatin, suspension buvable/buccale
Galenic form
SUM
ATC Code
A07AA02
Authorization status
Z
Dispensation category
B
First authorization
18/05/1967
Authorization expiration date
31/12/9999
IT number
08.06.0.
Domain
Human medicine

Packaging details

Description (FR)
MYCOSTATIN susp 100000 U/ml fl 24 ml
Description (DE)
MYCOSTATIN Susp 100000 E/ml Fl 24 ml
Market launch
18/05/1967
Narcotic (BTM)
No

Available generics

Multilind, Suspension zum Einnehmen
CHF 11.80
View
Multilind, Suspension zum Einnehmen
CHF 11.80
View
Multilind, Suspension zum Einnehmen
CHF 13.70
View